1. Prophylaxis in children with haemophilia – the Polish experience. (20th November 2013) Authors: Klukowska, A.; Urasinski, T.; Janik‐Moszant, A.; Bobrowska, H.; Balwierz, W.; Woznica‐Karczmarz, I.; Dobaczewski, G.; Wlazlowski, M.; Koltan, A.; Badowska, W.; Dakowicz, L.; Karolczyk, G.; Kostrzewska, M.; Korczowski, B.; Wasinski, D.; Pietrys, D.; Laguna, P.; Wysocka, M. Journal: Haemophilia Issue: Volume 20:Number 1(2014:Jan.) Page Start: e108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics. (8th May 2013) Authors: Kulkarni, R.; Karim, F. A.; Glamocanin, S.; Janic, D.; Vdovin, V.; Ozelo, M.; Rageliene, L.; Carboni, E.; Laguna, P.; Dobaczewski, G.; Seremetis, S.; Lindblom, A.; Santagostino, E. Journal: Haemophilia Issue: Volume 19:Number 5(2013:Sep.) Page Start: 698 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗